How does 0EL9's PS Ratio compare to its peers?

0EL9 is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (13.9x).

How does 0EL9's PS Ratio compare vs other companies in the GB Medical Equipment Industry?

0EL9 is good value based on its Price-To-Sales Ratio (1x) compared to the UK Medical Equipment industry average (2.5x).

What is 0EL9's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate 0EL9's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of 0EL9 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

0EL9 (€3.5) is trading below our estimate of [[fair value]] (€5.8)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

0EL9 Stock Overview

Operates as a medical technology company in Germany. More details

0EL9 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	0/6
Financial Health	3/6
Dividends	1/6

Rewards

Trading at 39.7% below our estimate of its fair value

Earnings are forecast to grow 89.49% per year

Risk Analysis

Dividend of 2.92% is not well covered by earnings or free cash flows

Shares are highly illiquid

Does not have a meaningful market cap (€18M)

My Notes

Capture your thoughts, links and company narrative

Geratherm Medical AG Competitors

Polarean Imaging

AIM:POLX

UK£15.4m

Inspiration Healthcare Group

AIM:IHC

UK£11.4m

Ondine Biomedical

AIM:OBI

UK£34.5m

EMV Capital

AIM:EMVC

UK£11.9m

Price History & Performance

Summary of share price highs, lows and changes for Geratherm Medical
Historical stock prices
Current Share Price	€3.50
52 Week High	€5.70
52 Week Low	€2.82
Beta	0.047
1 Month Change	17.45%
3 Month Change	-18.98%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-53.01%

Recent updates

Shareholder Returns

	0EL9	GB Medical Equipment	GB Market
7D	-5.9%	-3.1%	-2.6%
1Y	n/a	-10.1%	2.7%

Return vs Industry: Insufficient data to determine how 0EL9 performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how 0EL9 performed against the UK Market.

Price Volatility

Is 0EL9's price volatile compared to industry and market?
0EL9 volatility
0EL9 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.5%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	10.5%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: 0EL9's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine 0EL9's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1990	179	Christian Frick	www.geratherm.com

Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors.

Geratherm Medical AG Fundamentals Summary

How do Geratherm Medical's earnings and revenue compare to its market cap?
0EL9 fundamental statistics
Market cap	€18.40m
Earnings (TTM)	-€830.50k
Revenue (TTM)	€18.31m

1.0x

P/S Ratio

-22.2x

P/E Ratio

Is 0EL9 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0EL9 income statement (TTM)
Revenue	€18.31m
Cost of Revenue	€4.91m
Gross Profit	€13.39m
Other Expenses	€14.22m
Earnings	-€830.50k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.15
Gross Margin	73.16%
Net Profit Margin	-4.54%
Debt/Equity Ratio	30.8%

How did 0EL9 perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

-65%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 02:43
End of Day Share Price	2024/12/18 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Geratherm Medical AG is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Oliver Wojahn	mwb research AG
IGOR KIM	Oddo Seydler
Enid Omerovic	Oddo Seydler

Geratherm Medical LSE:0EL9 Stock Report